RELATED PARTY TRANSACTIONS (Details Textual) - USD ($) |
12 Months Ended | |
|---|---|---|
Dec. 31, 2015 |
Dec. 31, 2014 |
|
| Related Party Transaction [Line Items] | ||
| Amount Invoiced Under Clinical Trial Agreements | $ 496,000 | |
| Payment Towards Clinical Trial Agreements | $ 290,000 | |
| University Of Wisconsin Madison [Member] | ||
| Related Party Transaction [Line Items] | ||
| Due to Related Parties, Current | $ 40,000 | $ 353,000 |
| X | ||||||||||
- Definition Represents the amount invoiced under clinical trial agreements. No definition available.
|
| X | ||||||||||
- Definition Represents the cash outflow arising due to payment towards clinical trial agreement costs. No definition available.
|
| X | ||||||||||
- Definition Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|